Registry of Multiple Osteonchodromas
Launched by LUCA SANGIORGI · Oct 17, 2019
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called the Registry of Multiple Osteochondromas, is focused on studying a condition known as Multiple Osteochondroma, which is a type of bone disorder that can cause growths on the bones. The trial aims to gather detailed information about patients, including their personal and medical history, genetic background, and any surgeries they may have had. By collecting this information, researchers hope to better understand how the disease affects people and how genetic factors might influence the condition.
Anyone diagnosed with Multiple Osteochondromas, including those who have been diagnosed before birth, can participate in this study. The trial is currently recruiting participants of all ages and genders. If you join, you can expect to provide some information about your health and family history, which will help researchers learn more about the condition. This study is important because it aims to improve our understanding of Multiple Osteochondromas and could lead to better care and treatment options for those affected.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All Multiple Osteochondromas patients, including prenatal diagnosis of Multiple Osteochondromas
- Exclusion Criteria:
- • Any condition unrelated to Multiple Osteochondromas
About Luca Sangiorgi
Luca Sangiorgi is a dedicated clinical trial sponsor committed to advancing medical research and innovation. With a focus on developing novel therapies, Luca Sangiorgi leads initiatives that emphasize patient safety, scientific rigor, and ethical standards. The organization collaborates with leading research institutions and healthcare professionals to conduct clinical trials across various therapeutic areas, aiming to bring impactful treatments to market. Through strategic partnerships and a strong emphasis on data integrity, Luca Sangiorgi strives to enhance patient outcomes and contribute to the evolution of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bologna, Emilia Romagna, Italy
Patients applied
Trial Officials
Luca Sangiorgi, MD, PhD, MS
Principal Investigator
Istituto Ortopedico Rizzoli
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials